Background: One in ten adults in the United States has diabetes; the vast majority are diagnosed with type two diabetes mellitus (T2DM). Even though diabetes care has significantly evolved, and a wide variety of pharmacological treatments are available, approximately one-half of people with type two diabetes do not achieve a hemoglobin A1C of less than seven percent. In addition, self-management is a consequential contributor to glycemic control. In light of the mortality, morbidity, decreased quality of life, and financial burden caused by T2DM, the author wanted to explore the diagnosis experiences of type two diabetics. Could their experiences be a contributing factor to less-than-optimal treatment outcomes?
Methods:The author interviewed nine consenting adults with T2DM in person, over the telephone, and via videoconference over four weeks in March and April 2023. The data from each transcript was analyzed independently and then compared, identifying meanings and clustering themes found throughout utilizing descriptive phenomenology as the underpinning for this study.Results: Eight main themes emerged from the participant narratives. While distinct in themselves, many contained overlapping elements that influenced self-management, which was a theme of its own. Others included scarcity of information, emotions, experience with a provider, disease perception, minimalization of disease severity, the notoriety of Metformin, and flurry of diagnoses. Participant narratives were rich in detail and emotion.
Conclusion:The participants' personal experiences in this study suggest that care delivery at diagnosis impacts selfmanagement. The researcher respectfully exhorts providers to consider the impact a diagnosis experience has on newly diagnosed diabetics and those following up long-term.